The global pharmaceutical drug delivery market size reached US$ 1,325 Billion in 2022. Looking forward, the publisher expects the market to reach US$ 1,848 Billion by 2028, exhibiting a growth rate (CAGR) of 5.5% during 2023-2028.
Pharmaceutical drug delivery is a method of administering therapeutic substances into the body. It improves efficiency, safety, and patient experience by controlling the rate, time, and place of drug release. At present, different types of drug delivery systems are available for the release of various therapeutic agents. For instance, gels, liposomes, microspheres, prodrugs, and cyclodextrins are among the effective systems used for peptide and protein therapeutics.
Pharmaceutical drug delivery is a method of administering therapeutic substances into the body. It improves efficiency, safety, and patient experience by controlling the rate, time, and place of drug release. At present, different types of drug delivery systems are available for the release of various therapeutic agents. For instance, gels, liposomes, microspheres, prodrugs, and cyclodextrins are among the effective systems used for peptide and protein therapeutics.
Pharmaceutical Drug Delivery Market Trends:
The growing prevalence of diseases, such as respiratory, leishmaniasis, central nervous system (CNS), and systemic fungal infections, represents one of the key factors bolstering the market growth. Moreover, a significant increase in the number of death rates among the older population and individuals who have cancer is catalyzing the demand for pharmaceutical drug delivery systems. These systems provide enhanced efficacy and reduced toxicity for anticancer agents. The market is also influenced by consumer inclination towards personalized and minimally invasive (MI) medical therapy. Apart from this, nanoparticles composed of biodegradable polymers are gaining popularity for enhancing drug delivery to the brain. They also assist in fulfilling the stringent requirements placed on drug delivery systems by governing agencies of numerous countries. These requirements generally include stability against forces generated during aerosolization, biocompatibility, targeting specific sites or cell populations in the lung, drug release in a predetermined manner, and degradation within an acceptable period. In line with this, researchers are focusing on developing new drug delivery systems, which is contributing to market growth. Furthermore, with the surging cases of coronavirus disease (COVID-19) across the globe, there is a rise in the demand for pharmaceutical drugs, which, in turn, is anticipated to fuel the market growth.Key Market Segmentation:
The publisher provides an analysis of the key trends in each sub-segment of the global pharmaceutical drug delivery market report, along with forecasts at the global, regional and country level from 2023-2028. The report has categorized the market based on route of administration, application and end user.Breakup by Route of Administration:
- Oral Drug Delivery
- Injectable Drug Delivery
- Topical Drug Delivery
- Ocular Drug Delivery
- Pulmonary Drug Delivery
- Implantable Drug Delivery
- Transmucosal Drug Delivery
- Nasal Drug Delivery
Breakup by Application:
- Infectious Diseases
- Cancer
- Cardiovascular Diseases
- Diabetes
- Respiratory Diseases
- Central Nervous System Disorders
- Autoimmune Diseases
- Others
Breakup by End User:
- Hospitals
- Ambulatory Surgery Centers
- Home Care Settings
- Diagnostic Centers
- Others
Breakup by Region:
- North America
- United States
- Canada
- Asia-Pacific
- China
- Japan
- India
- South Korea
- Australia
- Indonesia
- Others
- Europe
- Germany
- France
- United Kingdom
- Italy
- Spain
- Russia
- Others
- Latin America
- Brazil
- Mexico
- Others
- Middle East and Africa
Competitive Landscape:
The competitive landscape of the industry has also been examined along with the profiles of the key players being AbbVie Inc., Amgen Inc., AstraZeneca plc, Becton Dickinson and Company, Eli Lilly and Company, GSK plc, Johnson & Johnson, Merck KGaA, Novartis AG, Pfizer Inc. and Sanofi S.A.Key Questions Answered in This Report:
- How has the global pharmaceutical drug delivery market performed so far and how will it perform in the coming years?
- What has been the impact of COVID-19 on the global pharmaceutical drug delivery market?
- What are the key regional markets?
- What is the breakup of the market based on the route of administration?
- What is the breakup of the market based on the application?
- What is the breakup of the market based on the end user?
- What are the various stages in the value chain of the industry?
- What are the key driving factors and challenges in the industry?
- What is the structure of the global pharmaceutical drug delivery market and who are the key players?
- What is the degree of competition in the industry?
Table of Contents
1 Preface3 Executive Summary11 Value Chain Analysis13 Price Analysis
2 Scope and Methodology
4 Introduction
5 Global Pharmaceutical Drug Delivery Market
6 Market Breakup by Route of Administration
7 Market Breakup by Application
8 Market Breakup by End User
9 Market Breakup by Region
10 SWOT Analysis
12 Porters Five Forces Analysis
14 Competitive Landscape
Companies Mentioned
- AbbVie Inc.
- Amgen Inc.
- AstraZeneca plc
- Becton Dickinson
- Company
- Eli Lilly and Company
- GSK plc
- Johnson & Johnson
- Merck KGaA
- Novartis AG
- Pfizer Inc. and Sanofi S.A.
Methodology
LOADING...
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 138 |
Published | September 2023 |
Forecast Period | 2022 - 2028 |
Estimated Market Value ( USD | $ 1325 Billion |
Forecasted Market Value ( USD | $ 1848 Billion |
Compound Annual Growth Rate | 5.7% |
Regions Covered | Global |
No. of Companies Mentioned | 11 |